<VariationArchive RecordType="classified" VariationID="1443489" VariationName="NM_000043.6(FAS):c.312dup (p.Arg105Ter)" VariationType="Duplication" Accession="VCV001443489" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2022-03-28" MostRecentSubmission="2022-03-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1384435" VariationID="1443489">
      <GeneList>
        <Gene Symbol="FAS" FullName="Fas cell surface death receptor" GeneID="355" HGNC_ID="HGNC:11920" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q23.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="88964050" stop="89017059" display_start="88964050" display_stop="89017059" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="90750287" stop="90775541" display_start="90750287" display_stop="90775541" Strand="+" />
          </Location>
          <OMIM>134637</OMIM>
          <Haploinsufficiency last_evaluated="2022-02-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FAS">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-02-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FAS">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000043.6(FAS):c.312dup (p.Arg105Ter)</Name>
      <CanonicalSPDI>NC_000010.11:89007814:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>10q23.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="89007814" stop="89007815" display_start="89007814" display_stop="89007815" variantLength="1" positionVCF="89007814" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="90767571" stop="90767572" display_start="90767571" display_stop="90767572" variantLength="1" positionVCF="90767571" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <ProteinChange>R105*</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.90767572dup" Assembly="GRCh37">
            <Expression>NC_000010.10:g.90767572dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.89007815dup" Assembly="GRCh38">
            <Expression>NC_000010.11:g.89007815dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009089.2" sequenceAccession="NG_009089" sequenceVersion="2" change="g.22285dup">
            <Expression>NG_009089.2:g.22285dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000043.6" sequenceAccession="NM_000043" sequenceVersion="6" change="c.312dup" MANESelect="true">
            <Expression>NM_000043.6:c.312dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000034.1" sequenceAccession="NP_000034" sequenceVersion="1" change="p.Arg105Ter">
            <Expression>NP_000034.1:p.Arg105Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001320619.2" sequenceAccession="NM_001320619" sequenceVersion="2" change="c.312dup">
            <Expression>NM_001320619.2:c.312dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001307548.1" sequenceAccession="NP_001307548" sequenceVersion="1" change="p.Arg105Ter">
            <Expression>NP_001307548.1:p.Arg105Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_152871.4" sequenceAccession="NM_152871" sequenceVersion="4" change="c.312dup">
            <Expression>NM_152871.4:c.312dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_690610.1" sequenceAccession="NP_690610" sequenceVersion="1" change="p.Arg105Ter">
            <Expression>NP_690610.1:p.Arg105Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_152872.4" sequenceAccession="NM_152872" sequenceVersion="4" change="c.312dup">
            <Expression>NM_152872.4:c.312dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_690611.1" sequenceAccession="NP_690611" sequenceVersion="1" change="p.Arg105Ter">
            <Expression>NP_690611.1:p.Arg105Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_028033.4" sequenceAccession="NR_028033" sequenceVersion="4" change="n.391dup">
            <Expression>NR_028033.4:n.391dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_028036.4" sequenceAccession="NR_028036" sequenceVersion="4" change="n.391dup">
            <Expression>NR_028036.4:n.391dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_135313.2" sequenceAccession="NR_135313" sequenceVersion="2" change="n.391dup">
            <Expression>NR_135313.2:n.391dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_135314.2" sequenceAccession="NR_135314" sequenceVersion="2" change="n.478dup">
            <Expression>NR_135314.2:n.478dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_134" sequenceAccession="LRG_134">
            <Expression>LRG_134:g.22285dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2133503921" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000043.6(FAS):c.312dup (p.Arg105Ter) AND Autoimmune lymphoproliferative syndrome type 1" Accession="RCV001987558" Version="1">
        <ClassifiedConditionList TraitSetID="6277">
          <ClassifiedCondition DB="MedGen" ID="C1328840">Autoimmune lymphoproliferative syndrome type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-03-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-03-28" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2022-03-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10875918</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22237435</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6277" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="369" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Autoimmune lymphoproliferative syndrome type 1, autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autoimmune lymphoproliferative syndrome type 1</ElementValue>
                <XRef ID="MONDO:0011158" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE I, AUTOSOMAL DOMINANT</ElementValue>
                <XRef Type="MIM" ID="601859" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ALPS</ElementValue>
                <XRef Type="MIM" ID="601859" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Autoimmune lymphoproliferative syndrome (ALPS), caused by defective lymphocyte homeostasis, is characterized by the following: Non-malignant lymphoproliferation (lymphadenopathy, hepatosplenomegaly with or without hypersplenism) that often improves with age. Autoimmune disease, mostly directed toward blood cells. Lifelong increased risk for both Hodgkin and non-Hodgkin lymphoma. In ALPS-FAS (the most common and best-characterized type of ALPS, associated with heterozygous germline pathogenic variants in FAS), non-malignant lymphoproliferation typically manifests in the first years of life, inexplicably waxes and wanes, and then often decreases without treatment in the second decade of life; in many affected individuals, however, neither splenomegaly nor the overall expansion of lymphocyte subsets in peripheral blood decreases. Although autoimmunity is often not present at the time of diagnosis or at the time of the most extensive lymphoproliferation, autoantibodies can be detected before autoimmune disease manifests clinically. In ALPS-FAS caused by homozygous or compound heterozygous (biallelic) pathogenic variants in FAS, severe lymphoproliferation occurs before, at, or shortly after birth, and usually results in death at an early age. ALPS-sFAS, resulting from somatic FAS pathogenic variants in selected cell populations, notably the alpha/beta double-negative T cells (a/ÃŸ-DNT cells), appears to be similar to ALPS-FAS resulting from heterozygous germline pathogenic variants in FAS, although lower incidence of splenectomy and lower lymphocyte counts have been reported in ALPS-sFAS and no cases of lymphoma have yet been published.</Attribute>
                <XRef ID="NBK1108" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301287</ID>
                <ID Source="BookShelf">NBK1108</ID>
              </Citation>
              <Citation Type="general" Abbrev="NIH, 2009">
                <ID Source="pmc">2953894</ID>
              </Citation>
              <XRef ID="3261" DB="Orphanet" />
              <XRef ID="C1328840" DB="MedGen" />
              <XRef ID="MONDO:0011158" DB="MONDO" />
              <XRef Type="MIM" ID="601859" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4244919" SubmissionDate="2022-03-23" DateLastUpdated="2022-03-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="13319236|MedGen:C1328840" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002223346" DateUpdated="2022-03-28" DateCreated="2022-03-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10875918</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22237435</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Arg105*) in the FAS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FAS are known to be pathogenic (PMID: 10875918, 22237435). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with FAS-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FAS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.90767571_90767572insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1328840" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4244919" TraitType="Disease" MappingType="XRef" MappingValue="C1328840" MappingRef="MedGen">
        <MedGen CUI="C1328840" Name="Autoimmune lymphoproliferative syndrome type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

